Navigation Links
Optogenetic tool elucidated
Date:2/28/2012

Controlling nerve cells with the aid of light: this is made possible by optogenetics. It enables, for example, the investigation of neurobiological processes with unprecedented spatial and temporal precision. The key tool of optogenetics is the light-activated protein channelrhodopsin. Biophysicists from Bochum and Berlin have now succeeded in explaining the switching mechanism through an interdisciplinary approach. The researchers report on their findings in the Journal of Biological Chemistry.

Redistribution of water molecules

Until now, little has been known about the mechanism of the protein - especially about how the channel opens. However, deeper understanding is a prerequisite in order to be able to use the light-controlled protein specifically for neurobiological applications. In a new, multi-disciplinary approach, the Bochum scientists led by Prof. Dr. Klaus Gerwert (Department of Biophysics at the RUB) and their cooperation partners in Berlin have been able to shed light on the switching mechanism. The result: the light-induced change in the charge state of amino acid glutamate 90 (E90) triggers an increased penetration of water molecules, so that the protein can now purposefully conduct ions through the cell membrane.

Three methods combined

Using time-resolved infrared spectroscopy, the RUB biophysicists Jens Kuhne and Dr. Erik Freier have been able to show for the first time that the channel is opened through the deprotonation of the amino acid glutamate 90 (E90). In addition, the electrophysiological experiments of the researchers in Berlin confirm that a mutation of the amino acid leads to a change in the ion permeability of the protein. Instead of using safety goggles and lab coats, the two biophysicists Kirstin Eisenhauer and Dr. Steffen Wolf at the Department of Biophysics used supercomputers to simulate how the protonation change of the glutamate opens the channel and allows water molecules to penetrate.

Internationally preeminent

The work has attained particular distinction right now, because shortly after the Bochum pre-publication on the Internet, Japanese researchers published the three-dimensional structure of a channelrhodopsin online in "Nature". "The structure work impressively confirms our biomolecular simulations and the key role played by the amino acid E90 in the switching of the channel", says Prof. Klaus Gerwert. "We are therefore particularly proud to have been preeminent in this internationally competitive field." In 2010, optogenetics was distinguished by "Nature Methods" as the "Method of the Year". Using this method, researchers have succeeded, for example, in restoring the eyesight of blind mice.


'/>"/>

Contact: Dr. Klaus Gerwert
gerwert@bph.rub.de
49-234-322-4461
Ruhr-University Bochum
Source:Eurekalert

Related biology news :

1. Light workout: Stanford scientists use optogenetics to effectively stimulate muscle movement in mice
2. The leading edge of stress: New genomic, optogenetic and epigenetic findings
3. Connection elucidated between obesity, salt sensitivity and high blood pressure
4. A new signaling pathway of the immune system is elucidated
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/15/2016)... Rico , Jan. 15, 2016 Recent ... and small to find new ways to ensure data ... iOS and Android that ... on biometrics, transforming it into a hardware authorization token. ... users swipe their fingerprint on their KodeKey enabled device ...
(Date:1/11/2016)... Calif. , Jan. 11, 2016 Synaptics ... human interface solutions, today announced that its ClearPad ® ... integration (TDDI) products won two separate categories in the ... Mobile Innovator and Best Technology Breakthrough. The Synaptics ® ... cost, a simplified supply chain, thinner devices, brighter displays ...
(Date:1/8/2016)... 8, 2016 NXTD ), a ... ® , a privately held leading direct seller of ... 5000 fastest-growing company announced that on December 31, ... million in Nxt-ID to develop a proprietary new wireless ... ® , a unique smart wallet that serves to ...
Breaking Biology News(10 mins):
(Date:2/9/2016)... ... February 09, 2016 , ... ... innovations on its free and validated Electronic Data Capture (EDC) system ClinCaptureand its ... in Clinical Trials West Coast 2016 Conference in San Mateo, California on February ...
(Date:2/9/2016)... HOUSTON , Feb. 9, 2016 /PRNewswire/ ... virus-driven immunotherapies for cancer, announced that its ... the European Commission as an orphan medicinal ... the deadliest form of glioma, strikes approximately ... and EU. http://photos.prnewswire.com/prnh/20160208/330986LOGO ...
(Date:2/9/2016)... 9, 2016 DelveInsight,s, ... report provides in depth insights on the ... the Protein-Tyrosine Phosphatase 1B (PTP1B) Inhibitors. The ... various stages of development including Discovery, Pre-clinical, ... and Preregistration. Report covers the product clinical ...
(Date:2/8/2016)... Inc. today announced that Director Robert A. Ingram has ... addition, Robert Keegan has been appointed to the Board ... --> North Carolina . --> ... $32.8 million of net proceeds in a private Mezzanine B financing ... Research Triangle area of North Carolina . ...
Breaking Biology Technology: